COM:SYNEOSHEALTH
Syneos Health
- Stock
Last Close
42.97
27/09 20:00
Market Cap
4.46B
Beta: -
Volume Today
6.70M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 12.49M - | 15.81M 26.59% | 8.57M 45.83% | 529.50K 93.82% | 660.50K 24.74% | 357K 45.95% | ||||||
average payables | 13.37M - | 13.07M 2.21% | 19.52M 49.36% | 23.09M 18.30% | 41.13M 78.11% | 78.60M 91.08% | 117.66M 49.69% | 125.19M 6.40% | 110.61M 11.64% | 113.08M 2.23% | ||
average receivables | 228.05M - | 238.60M 4.63% | 273.19M 14.50% | 341.68M 25.07% | 700.67M 105.07% | 1.14B 62.18% | 1.28B 12.66% | 1.32B 3.44% | 1.43B 8.35% | 1.59B 10.47% | ||
book value per share | 5.31 - | 7.36 38.56% | 3.76 48.95% | 5.58 48.55% | 40.35 623.13% | 27.62 31.55% | 29.24 5.87% | 31.12 6.45% | 32.85 5.56% | 33.94 3.31% | ||
capex per share | -0.34 - | -0.48 40.75% | -0.36 23.92% | -0.58 59.12% | -0.59 0.98% | -0.53 9.90% | -0.62 16.95% | -0.48 22.24% | -0.55 13.98% | -0.91 65.86% | ||
capex to depreciation | -0.30 - | -0.47 54.63% | -0.38 19.55% | -0.53 40.51% | -0.24 53.93% | -0.20 18.23% | -0.26 32.27% | -0.22 14.76% | -0.24 7.26% | -0.38 56.74% | ||
capex to operating cash flow | -0.48 - | -0.19 59.10% | -0.10 46.95% | -0.29 178.12% | -0.22 22.79% | -0.18 18.74% | -0.20 11.65% | -0.12 41.49% | -0.13 7.40% | -0.22 73.39% | ||
capex to revenue | -0.02 - | -0.02 21.76% | -0.02 30.39% | -0.02 29.03% | -0.02 15.61% | -0.01 24.30% | -0.01 10.02% | -0.01 17.22% | -0.01 3.72% | -0.02 58.93% | ||
cash per share | 1.86 - | 2.37 27.24% | 1.47 38.10% | 1.90 29.14% | 4.29 126.12% | 1.51 64.84% | 1.58 4.77% | 2.61 65.40% | 1.03 60.77% | 1.09 6.11% | ||
days of inventory on hand | 7.04 - | 6.89 2.18% | 0.16 97.67% | 0.18 14.26% | 0.13 30.79% | |||||||
days payables outstanding | 4.52 - | 6.83 51.18% | 8.00 17.05% | 7.17 10.39% | 10.42 45.46% | 10.48 0.57% | 13.68 30.55% | 12.21 10.76% | 9.83 19.53% | 10.46 6.46% | ||
days sales outstanding | 83.94 - | 76.90 8.38% | 77.74 1.08% | 87.33 12.34% | 138.78 58.92% | 104.49 24.71% | 101.76 2.61% | 111.16 9.23% | 106.77 3.95% | 111.34 4.28% | ||
debt to assets | 0.48 - | 0.34 30.03% | 0.41 22.83% | 0.39 6.77% | 0.41 6.87% | 0.39 5.58% | 0.39 0.50% | 0.40 1.79% | 0.37 6.24% | 0.35 5.43% | ||
debt to equity | 2.15 - | 1.07 50.25% | 2.31 115.54% | 1.65 28.47% | 1.00 39.73% | 0.99 0.51% | 0.96 2.66% | 0.99 2.90% | 0.90 9.00% | 0.83 8.08% | ||
dividend yield | 0.00 - | 0.00 41.63% | ||||||||||
earnings yield | -0.04 - | -0.02 56.02% | 0.04 343.18% | 0.04 4.92% | -0.04 206.98% | 0.01 114.08% | 0.02 256.94% | 0.03 27.53% | 0.02 18.95% | 0.07 220.45% | ||
enterprise value | 1.56B - | 1.66B 6.38% | 3.22B 93.95% | 3.24B 0.38% | 5.95B 83.88% | 6.74B 13.24% | 8.92B 32.29% | 10.04B 12.58% | 13.64B 35.85% | 6.56B 51.87% | ||
enterprise value over ebitda | 15.30 - | 11.12 27.32% | 14.78 32.97% | 14.76 0.19% | 18.63 26.25% | 11.59 37.76% | 15.73 35.66% | 17.37 10.41% | 20.78 19.66% | 9.38 54.87% | ||
ev to operating cash flow | 41.94 - | 12.65 69.84% | 15.75 24.52% | 29.61 87.98% | 30.02 1.40% | 22.21 26.01% | 28.00 26.05% | 23.60 15.74% | 30.29 28.37% | 15.37 49.25% | ||
ev to sales | 1.57 - | 1.41 10.20% | 2.30 63.39% | 2.01 12.79% | 2.23 10.83% | 1.54 31.07% | 1.91 24.21% | 2.27 19.21% | 2.62 15.07% | 1.22 53.48% | ||
free cash flow per share | 0.38 - | 1.99 428.38% | 3.17 59.66% | 1.44 54.50% | 2.06 42.77% | 2.41 16.78% | 2.46 2.07% | 3.60 46.75% | 3.79 5.08% | 3.24 14.49% | ||
free cash flow yield | 0.02 - | 0.08 321.43% | 0.07 15.44% | 0.03 58.04% | 0.05 72.25% | 0.06 29.40% | 0.04 32.46% | 0.05 28.10% | 0.04 30.28% | 0.09 139.37% | ||
graham net net | -13.09 - | -9.98 23.78% | -11.83 18.61% | -11.02 6.90% | -42.44 285.28% | -31.91 24.81% | -31.68 0.73% | -33.99 7.28% | -34.41 1.25% | -32.61 5.23% | ||
graham number | 9.77 - | 8.54 12.59% | 13.07 53.10% | 16.18 23.75% | 40.96 153.22% | 12.08 70.51% | 28.87 138.98% | 36.00 24.71% | 40.88 13.55% | 44.46 8.75% | ||
income quality | -0.90 - | -5.60 524.06% | 1.75 131.23% | 0.97 44.51% | -1.43 247.50% | 12.50 972.74% | 2.43 80.58% | 2.21 9.04% | 1.92 13.12% | 1.60 16.44% | ||
intangibles to total assets | 0.64 - | 0.60 6.85% | 0.58 2.96% | 0.52 11.11% | 0.77 47.92% | 0.75 1.59% | 0.71 5.22% | 0.71 0.85% | 0.71 0.39% | 0.68 3.54% | 0 100% | |
interest coverage | 0.52 - | 1.20 131.93% | 9.74 711.80% | 12.93 32.72% | -0.45 103.50% | 1.23 370.56% | 2.50 103.98% | 3.23 29.03% | 4.92 52.49% | 4.99 1.46% | ||
interest debt per share | 12.60 - | 8.87 29.56% | 8.94 0.73% | 9.43 5.54% | 41.00 334.59% | 28.61 30.23% | 29.43 2.87% | 31.73 7.83% | 30.41 4.18% | 28.94 4.84% | ||
inventory turnover | 51.85 - | 53.00 2.23% | 2.27K 4,186.70% | 1.99K 12.48% | 2.87K 44.49% | |||||||
invested capital | 2.15 - | 1.07 50.25% | 2.31 115.54% | 1.65 28.47% | 1.00 39.73% | 0.99 0.51% | 0.96 2.66% | 0.99 2.90% | 0.90 9.00% | 0.83 8.08% | ||
market cap | 1.07B - | 1.37B 28.49% | 2.81B 105.08% | 2.84B 1.21% | 3.27B 14.93% | 4.07B 24.59% | 6.16B 51.43% | 7.10B 15.17% | 10.67B 50.28% | 3.78B 64.59% | ||
net current asset value | -580.72M - | -425.98M 26.65% | -571.74M 34.22% | -464.40M 18.77% | -2.84B 511.77% | -2.91B 2.31% | -2.86B 1.54% | -3.08B 7.73% | -3.06B 0.81% | -2.76B 9.74% | ||
net debt to ebitda | 4.87 - | 1.96 59.69% | 1.91 2.64% | 1.80 5.72% | 8.41 366.66% | 4.60 45.34% | 4.86 5.77% | 5.09 4.72% | 4.53 11.01% | 3.98 12.10% | ||
net income per share | -0.80 - | -0.44 44.86% | 2.02 559.19% | 2.08 3.10% | -1.85 188.67% | 0.23 112.70% | 1.27 439.45% | 1.85 46.10% | 2.26 22.16% | 2.59 14.47% | ||
operating cash flow per share | 0.72 - | 2.47 244.14% | 3.54 43.42% | 2.02 42.79% | 2.65 30.79% | 2.93 10.87% | 3.07 4.75% | 4.08 32.90% | 4.33 6.13% | 4.15 4.35% | ||
payables turnover | 80.77 - | 53.43 33.85% | 45.65 14.57% | 50.94 11.59% | 35.02 31.25% | 34.82 0.56% | 26.67 23.40% | 29.89 12.06% | 37.15 24.27% | 34.89 6.07% | ||
receivables turnover | 4.35 - | 4.75 9.14% | 4.70 1.07% | 4.18 10.98% | 2.63 37.07% | 3.49 32.82% | 3.59 2.68% | 3.28 8.45% | 3.42 4.11% | 3.28 4.11% | ||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | -0.09 - | -0.05 50.20% | 0.23 590.82% | 0.18 21.68% | -0.08 144.76% | 0.01 116.74% | 0.06 353.69% | 0.08 32.94% | 0.10 18.12% | 0.10 5.09% | ||
revenue per share | 19.13 - | 22.12 15.59% | 24.17 9.29% | 29.81 23.32% | 35.67 19.66% | 42.45 19.02% | 45.13 6.30% | 42.39 6.06% | 50.19 18.39% | 52.37 4.36% | ||
roe | -0.15 - | -0.06 60.20% | 0.54 999.57% | 0.37 30.60% | -0.05 112.26% | 0.01 118.56% | 0.04 409.56% | 0.06 37.25% | 0.07 15.72% | 0.08 10.81% | ||
roic | 0.05 - | 0.07 33.65% | 0.19 190.46% | 0.16 13.76% | -0.01 103.61% | 0.01 301.54% | 0.07 463.73% | 0.04 38.73% | 0.04 4.13% | 0.05 19.77% | ||
sales general and administrative to revenue | 0.09 - | |||||||||||
shareholders equity per share | 5.31 - | 7.36 38.56% | 3.76 48.95% | 5.58 48.55% | 40.35 623.13% | 27.62 31.55% | 29.24 5.87% | 31.12 6.45% | 32.85 5.56% | 33.94 3.31% | ||
stock based compensation to revenue | 0.00 - | 0.00 17.60% | 0.00 26.84% | 0.01 140.05% | 0.02 156.65% | 0.01 65.00% | 0.01 50.98% | 0.01 12.22% | 0.01 5.57% | 0.01 15.10% | ||
tangible asset value | -518.21M - | -355.01M 31.49% | -487.91M 37.44% | -365.51M 25.09% | -2.56B 599.30% | -2.61B 2.14% | -2.29B 12.14% | -2.47B 7.58% | -2.40B 2.84% | -2.08B 13.10% | ||
tangible book value per share | -9.96 - | -6.66 33.15% | -8.43 26.55% | -6.76 19.74% | -34.12 404.37% | -25.24 26.01% | -22.14 12.31% | -23.69 7.01% | -23.08 2.56% | -20.23 12.35% | ||
working capital | 58.17M - | 47.10M 19.03% | -52.55M 211.56% | 55.90M 206.39% | 262.62M 369.78% | -11.24M 104.28% | 45.70M 506.76% | 160.68M 251.58% | 112.34M 30.09% | 219.25M 95.16% |
All numbers in (except ratios and percentages)